Safety and effectiveness of direct-acting antivirals in patients with chronic hepatitis C and chronic kidney disease

BACKGROUND/AIMS: To evaluate the effectiveness and safety of direct acting antivirals (DAAs) available in chronic kidney disease (CKD) patients with hepatitis C virus (HCV) infection in Korea. METHODS: In a retrospective, multicenter cohort study, 362 patients were enrolled from 2015 to 2019. The ef...

Descripción completa

Detalles Bibliográficos
Autores principales: Ryu, Ji Eun, Song, Myeong Jun, Kim, Seok-Hwan, Kwon, Jung Hyun, Yoo, Sun Hong, Nam, Soon Woo, Nam, Hee Chul, Kim, Hee Yeon, Kim, Chang Wook, Yang, Hyun, Bae, Si Hyun, Song, Do Seon, Chang, U Im, Yang, Jin Mo, Lee, Sung Won, Lee, Hae Lim, Lee, Soon Kyu, Sung, Pil Soo, Jang, Jeong Won, Choi, Jong Young, Yoon, Seung Kew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Association of Internal Medicine 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9449192/
https://www.ncbi.nlm.nih.gov/pubmed/35981893
http://dx.doi.org/10.3904/kjim.2021.486

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9449192/
https://www.ncbi.nlm.nih.gov/pubmed/35981893
http://dx.doi.org/10.3904/kjim.2021.486

Ejemplares similares